These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 9614141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms by which oxygen regulates gene expression and cell-cell interaction in the vasculature.
    Kourembanas S, Morita T, Liu Y, Christou H.
    Kidney Int; 1997 Feb; 51(2):438-43. PubMed ID: 9027718
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide.
    Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H.
    Blood; 2000 Jan 01; 95(1):189-97. PubMed ID: 10607702
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
    Koyama S, Takagi H, Otani A, Oh H, Nishimura K, Honda Y.
    Br J Pharmacol; 2002 Nov 01; 137(6):901-9. PubMed ID: 12411422
    [Abstract] [Full Text] [Related]

  • 5. Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide.
    Kimura H, Weisz A, Ogura T, Hitomi Y, Kurashima Y, Hashimoto K, D'Acquisto F, Makuuchi M, Esumi H.
    J Biol Chem; 2001 Jan 19; 276(3):2292-8. PubMed ID: 11056166
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer.
    Büchler P, Reber HA, Büchler M, Shrinkante S, Büchler MW, Friess H, Semenza GL, Hines OJ.
    Pancreas; 2003 Jan 19; 26(1):56-64. PubMed ID: 12499918
    [Abstract] [Full Text] [Related]

  • 7. Induction of vascular endothelial growth factor in human astrocytes by lead. Involvement of a protein kinase C/activator protein-1 complex-dependent and hypoxia-inducible factor 1-independent signaling pathway.
    Hossain MA, Bouton CM, Pevsner J, Laterra J.
    J Biol Chem; 2000 Sep 08; 275(36):27874-82. PubMed ID: 10882716
    [Abstract] [Full Text] [Related]

  • 8. Regulation of insulin-like growth factor-binding protein-1 by nitric oxide under hypoxic conditions.
    Sugawara J, Suh DS, Faessen GH, Suen LF, Shibata T, Kaper F, Giaccia AJ, Giudice LC.
    J Clin Endocrinol Metab; 2000 Aug 08; 85(8):2714-21. PubMed ID: 10946870
    [Abstract] [Full Text] [Related]

  • 9. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells.
    Damert A, Ikeda E, Risau W.
    Biochem J; 1997 Oct 15; 327 ( Pt 2)(Pt 2):419-23. PubMed ID: 9359410
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells.
    El Awad B, Kreft B, Wolber EM, Hellwig-Bürgel T, Metzen E, Fandrey J, Jelkmann W.
    Kidney Int; 2000 Jul 15; 58(1):43-50. PubMed ID: 10886548
    [Abstract] [Full Text] [Related]

  • 11. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity.
    Rivard A, Berthou-Soulie L, Principe N, Kearney M, Curry C, Branellec D, Semenza GL, Isner JM.
    J Biol Chem; 2000 Sep 22; 275(38):29643-7. PubMed ID: 10882714
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling.
    Huang LE, Willmore WG, Gu J, Goldberg MA, Bunn HF.
    J Biol Chem; 1999 Mar 26; 274(13):9038-44. PubMed ID: 10085152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of YC-1 on the hypoxic induction of erythropoietin and vascular endothelial growth factor in Hep3B cells.
    Chun YS, Yeo EJ, Choi E, Teng CM, Bae JM, Kim MS, Park JW.
    Biochem Pharmacol; 2001 Apr 15; 61(8):947-54. PubMed ID: 11286986
    [Abstract] [Full Text] [Related]

  • 16. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
    Welsh SJ, Bellamy WT, Briehl MM, Powis G.
    Cancer Res; 2002 Sep 01; 62(17):5089-95. PubMed ID: 12208766
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
    Yamakawa M, Liu LX, Date T, Belanger AJ, Vincent KA, Akita GY, Kuriyama T, Cheng SH, Gregory RJ, Jiang C.
    Circ Res; 2003 Oct 03; 93(7):664-73. PubMed ID: 12958144
    [Abstract] [Full Text] [Related]

  • 19. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
    Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL.
    Mol Cell Biol; 2001 Jun 03; 21(12):3995-4004. PubMed ID: 11359907
    [Abstract] [Full Text] [Related]

  • 20. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity.
    Agani F, Semenza GL.
    Mol Pharmacol; 1998 Nov 03; 54(5):749-54. PubMed ID: 9804609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.